The invention relates to histone proteins and modified histone proteins for use in inhibiting the activity of complement, which also includes the medical use of modified histones in the treatment or prevention of diseases associated with enhanced complement activity. The invention further relates to modified histone proteins themselves, and to non-medical uses of histones for inhibiting complement activity in components of cell culture media.
展开▼
